<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Neural Therapeutics Inc. — News on 6ix</title>
<link>https://6ix.com/company/neural-therapeutics-inc</link>
<description>Latest news and press releases for Neural Therapeutics Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 27 Mar 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/neural-therapeutics-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6aea5beedb30cb6ff91c1.webp</url>
<title>Neural Therapeutics Inc.</title>
<link>https://6ix.com/company/neural-therapeutics-inc</link>
</image>
<item>
<title>Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-amendment-to-sio-agreement-concurrent-financing-terms-shareholder-meeting-date-and-rsu-grant</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-amendment-to-sio-agreement-concurrent-financing-terms-shareholder-meeting-date-and-rsu-grant</guid>
<pubDate>Fri, 27 Mar 2026 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has entered into a second amending agreement (the "SIO Amendment") to its strategic investment and option agreement dated May 26, 2025, as previously amended (the "SIO Agreement"), with CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers. The SIO Amendment provides, among other things, for a revised...</description>
</item>
<item>
<title>Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-cse-application-to-acquire-full-ownership-of-hanfcom-shareholder-meeting-sio-agreement-amendment-and-concurrent-financing</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-cse-application-to-acquire-full-ownership-of-hanfcom-shareholder-meeting-sio-agreement-amendment-and-concurrent-financing</guid>
<pubDate>Thu, 19 Feb 2026 13:53:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce that it has formally applied to the Canadian Securities Exchange (the "CSE") for approval to acquire the remaining 69.25% interest in CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers.Ronnie Jaegermann, Chief Executive Officer of CWE, stated: "Hanf.com has established a strong position in...</description>
</item>
<item>
<title>Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-portfolio-company-hanfcom-reports-strong-fiscal-2025-results-with-58percent-revenue-growth-and-positive-normalized-operating-income</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-portfolio-company-hanfcom-reports-strong-fiscal-2025-results-with-58percent-revenue-growth-and-positive-normalized-operating-income</guid>
<pubDate>Tue, 10 Feb 2026 12:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to report preliminary unaudited financial results for Hanf.com for...</description>
</item>
<item>
<title>Neural's Portfolio Company Hanf.com Announces Sales Start of Ritual Herbs Nicotine and Tobacco Free Products</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neurals-portfolio-company-hanfcom-announces-sales-start-of-ritual-herbs-nicotine-and-tobacco-free-products</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neurals-portfolio-company-hanfcom-announces-sales-start-of-ritual-herbs-nicotine-and-tobacco-free-products</guid>
<pubDate>Tue, 27 Jan 2026 15:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - January 27, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to announce that further to its press release of July 21, 2025, CWE...</description>
</item>
<item>
<title>Neural's Portfolio Company Hanf.com Expands Retail Footprint to Northern Germany with Two New Stores in Bielefeld and Herford</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neurals-portfolio-company-hanfcom-expands-retail-footprint-to-northern-germany-with-two-new-stores-in-bielefeld-and-herford</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neurals-portfolio-company-hanfcom-expands-retail-footprint-to-northern-germany-with-two-new-stores-in-bielefeld-and-herford</guid>
<pubDate>Thu, 06 Nov 2025 13:46:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, in which it owns 30.75% interest in, is pleased to announce the expansion of Hanf.com's retail network into northern...</description>
</item>
<item>
<title>Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-portfolio-company-hanfcom-reports-strong-fiscal-2024-results-with-65percent-revenue-growth-positive-cash-flow-and-double-digit-operating-margin-continued-growth-in-2025-first-half-revenues-up-31percent-year-over-year</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-portfolio-company-hanfcom-reports-strong-fiscal-2024-results-with-65percent-revenue-growth-positive-cash-flow-and-double-digit-operating-margin-continued-growth-in-2025-first-half-revenues-up-31percent-year-over-year</guid>
<pubDate>Wed, 08 Oct 2025 13:37:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 8, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on therapeutic solutions for mental health conditions, together with its portfolio company CWE European Holdings Inc. ("CWE", operating as Hanf.com), one of Germany's leading hemp- and CBD-based retail platforms, is pleased to report the audited financial results of Hanf.com for the fiscal year ended December 31,...</description>
</item>
<item>
<title>Neural's Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neurals-partner-hanfcom-expands-retail-footprint-with-17th-store-opening-near-munich</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neurals-partner-hanfcom-expands-retail-footprint-with-17th-store-opening-near-munich</guid>
<pubDate>Tue, 23 Sep 2025 16:16:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 23, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for substance use disorders, together with CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to announce the opening of its 17th retail location in the City of Freising, Bavaria. As disclosed in Neural's press release..</description>
</item>
<item>
<title>Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-announces-completion-of-the-acquisition-of-a-3075percent-interest-in-hanfcom-a-profitable-german-cbd-retail-store-chain</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-announces-completion-of-the-acquisition-of-a-3075percent-interest-in-hanfcom-a-profitable-german-cbd-retail-store-chain</guid>
<pubDate>Wed, 13 Aug 2025 11:30:00 GMT</pubDate>
<description>Transaction transforms Neural into company with solid financial fundamentals with significant short, mid and long-term growth prospects Hanf.com achieved sales of €4.9 Million (~CA$7.5M) and a 13% operating profit in 20241. Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and C</description>
</item>
<item>
<title>Neural Announces Approval of the Strategic Investment and Option Agreement by CWE Shareholders to Acquire up to 100% of CWE</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-announces-approval-of-the-strategic-investment-and-option-agreement-by-cwe-shareholders-to-acquire-up-to-100percent-of-cwe</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-announces-approval-of-the-strategic-investment-and-option-agreement-by-cwe-shareholders-to-acquire-up-to-100percent-of-cwe</guid>
<pubDate>Tue, 22 Jul 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's leading CBD retailers, are pleased to announce that all matters presented to shareholders of CWE, were approved at the special meeting of CWE share</description>
</item>
<item>
<title>Neural Advances Ethnobotanical Strategy Through Execution of SERFOR Research Agreement and CWE's Exclusive German Distribution Agreement with Ritual Herbs</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-advances-ethnobotanical-strategy-through-execution-of-serfor-research-agreement-and-cwes-exclusive-german-distribution-agreement-with-ritual-herbs</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-advances-ethnobotanical-strategy-through-execution-of-serfor-research-agreement-and-cwes-exclusive-german-distribution-agreement-with-ritual-herbs</guid>
<pubDate>Mon, 21 Jul 2025 12:53:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce two major developments that strengthen its ethnobotanical strategy: (i) its German partner CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's leading CBD retailers, has secured ex</description>
</item>
<item>
<title>Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neurals-partner-cwe-to-open-store-no-16-in-the-city-of-bonn-and-invitation-to-meet-hanfcom-at-mary-jane-berlin-2025</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neurals-partner-cwe-to-open-store-no-16-in-the-city-of-bonn-and-invitation-to-meet-hanfcom-at-mary-jane-berlin-2025</guid>
<pubDate>Fri, 06 Jun 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of the Germany's leading CBD retailers, are pleased to provide an update on expansion efforts in Germany. A subsidiary of CWE has signed a franchise agreement to ...</description>
</item>
<item>
<title>Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-and-hanfcom-sign-strategic-investment-and-option-agreement-to-create-a-science-backed-botanical-wellness-leader</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-and-hanfcom-sign-strategic-investment-and-option-agreement-to-create-a-science-backed-botanical-wellness-leader</guid>
<pubDate>Wed, 28 May 2025 17:52:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, and CWE European Holdings Inc. ("CWE"), operating as Hanf.com, a leading German CBD retailer, are pleased to announce the signing of a strategic investment and option agreement dated May 28, 2025 (the "SIO Agreement") for Neural to</description>
</item>
<item>
<title>Neural Therapeutics Announces RSU and Options Grant</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-rsu-and-options-grant</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-rsu-and-options-grant</guid>
<pubDate>Tue, 13 May 2025 20:31:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, announces that the Board of Directors approved the grant of 2,720,000 restricted share units ("RSUs") and 725,000 stock options ("Options").RSUs were granted to directors and consultants of Neural in accordance with the provisions o</description>
</item>
<item>
<title>Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM</title>
<link>https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-serfor-permit-renewal-submission-and-extension-of-loi-with-hanfcom</link>
<guid isPermaLink="true">https://6ix.com/company/neural-therapeutics-inc/news/neural-therapeutics-announces-serfor-permit-renewal-submission-and-extension-of-loi-with-hanfcom</guid>
<pubDate>Fri, 09 May 2025 12:26:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic drugs for mental illnesses related to substance use disorders, is pleased to announce that it has submitted a renewal application to Servicio Nacional Forestal y de Fauna Silvestre ("SERFOR"). SERFOR a specialized Peruvian technical governmental agency under the Ministry of Agriculture, responsi</description>
</item>
</channel>
</rss>